- Home
- CEP vs ATAI Comparison
CEP vs ATAI Comparison
Compare CEP & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEP
- ATAI
- Stock Information
- Founded
- CEP 2020
- ATAI 2018
- Country
- CEP United States
- ATAI Germany
- Employees
- CEP N/A
- ATAI N/A
- Industry
- CEP
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- CEP
- ATAI Health Care
- Exchange
- CEP NYSE
- ATAI Nasdaq
- Market Cap
- CEP 516.2M
- ATAI 444.7M
- IPO Year
- CEP 2024
- ATAI 2021
- Fundamental
- Price
- CEP $33.20
- ATAI $2.48
- Analyst Decision
- CEP
- ATAI Strong Buy
- Analyst Count
- CEP 0
- ATAI 3
- Target Price
- CEP N/A
- ATAI $10.50
- AVG Volume (30 Days)
- CEP 1.1M
- ATAI 2.7M
- Earning Date
- CEP 01-01-0001
- ATAI 08-12-2025
- Dividend Yield
- CEP N/A
- ATAI N/A
- EPS Growth
- CEP N/A
- ATAI N/A
- EPS
- CEP 0.25
- ATAI N/A
- Revenue
- CEP N/A
- ATAI $1,863,000.00
- Revenue This Year
- CEP N/A
- ATAI $554.22
- Revenue Next Year
- CEP N/A
- ATAI N/A
- P/E Ratio
- CEP $131.51
- ATAI N/A
- Revenue Growth
- CEP N/A
- ATAI 572.56
- 52 Week Low
- CEP $9.99
- ATAI $1.03
- 52 Week High
- CEP $59.75
- ATAI $2.64
- Technical
- Relative Strength Index (RSI)
- CEP N/A
- ATAI 66.50
- Support Level
- CEP N/A
- ATAI $2.06
- Resistance Level
- CEP N/A
- ATAI $2.55
- Average True Range (ATR)
- CEP 0.00
- ATAI 0.20
- MACD
- CEP 0.00
- ATAI -0.02
- Stochastic Oscillator
- CEP 0.00
- ATAI 72.41
About CEP CANTOR EQUITY PARTNERS INC
Cantor Equity Partners Inc is a blank check company.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.